MSR109 Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment: Case-Study on Bevacizumab
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2168
https://www.valueinhealthjournal.com/article/S1098-3015(23)05298-1/fulltext
Section Title :
Section Order :
11611
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05298-1&doi=10.1016/j.jval.2023.09.2168